DK0835114T3 - Farmaceutisk kombinationspræparat, kit og fremgangsmåde til den hormonale kontraception - Google Patents

Farmaceutisk kombinationspræparat, kit og fremgangsmåde til den hormonale kontraception

Info

Publication number
DK0835114T3
DK0835114T3 DK96922739T DK96922739T DK0835114T3 DK 0835114 T3 DK0835114 T3 DK 0835114T3 DK 96922739 T DK96922739 T DK 96922739T DK 96922739 T DK96922739 T DK 96922739T DK 0835114 T3 DK0835114 T3 DK 0835114T3
Authority
DK
Denmark
Prior art keywords
preparation
stage
daily
oestrogen
unit doses
Prior art date
Application number
DK96922739T
Other languages
English (en)
Inventor
Karin Schmidt-Gollwitzer
Walter Klemann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0835114T3 publication Critical patent/DK0835114T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Surgical Instruments (AREA)
DK96922739T 1995-06-28 1996-06-27 Farmaceutisk kombinationspræparat, kit og fremgangsmåde til den hormonale kontraception DK0835114T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19525017A DE19525017A1 (de) 1995-06-28 1995-06-28 Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
PCT/DE1996/001192 WO1997001342A1 (de) 1995-06-28 1996-06-27 Pharmazeutisches kombinationspräparat, kit und methode zur hormonalen kontrazeption

Publications (1)

Publication Number Publication Date
DK0835114T3 true DK0835114T3 (da) 2003-09-01

Family

ID=7766408

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96922739T DK0835114T3 (da) 1995-06-28 1996-06-27 Farmaceutisk kombinationspræparat, kit og fremgangsmåde til den hormonale kontraception

Country Status (22)

Country Link
US (2) US6027749A (da)
EP (1) EP0835114B1 (da)
JP (1) JPH11508538A (da)
CN (1) CN1137690C (da)
AT (1) ATE239483T1 (da)
AU (1) AU6352896A (da)
BR (1) BR9609317A (da)
CA (1) CA2225724C (da)
CZ (1) CZ420597A3 (da)
DE (2) DE19525017A1 (da)
DK (1) DK0835114T3 (da)
ES (1) ES2199293T3 (da)
HU (1) HU223976B1 (da)
IL (1) IL122109A (da)
MX (1) MX9800026A (da)
NO (1) NO317671B1 (da)
NZ (1) NZ312081A (da)
PT (1) PT835114E (da)
RU (1) RU98101254A (da)
SK (1) SK178097A3 (da)
WO (1) WO1997001342A1 (da)
ZA (1) ZA965547B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
WO1998004269A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6214815B1 (en) * 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
SI1598069T1 (sl) * 1999-08-31 2009-10-31 Bayer Schering Pharma Ag Farmacevtska kombinacija etinilestradiola in drospirenona za uporabo kot kontracepitev
US7297688B2 (en) 2000-06-08 2007-11-20 Wyeth Starter kit for low dose oral contraceptives
DE10045380A1 (de) 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
RU2351339C2 (ru) * 2001-12-05 2009-04-10 Дюрамед Фармасьютикалс, Инк. Оральные контрацептивы для предотвращения беременности и уменьшения предменструальной симптоматики
JP2007528358A (ja) * 2003-06-25 2007-10-11 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ジエノゲストを含んでなるホルモン置換療法および抑鬱療法
AU2004257772B2 (en) 2003-07-16 2009-12-17 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
EP1673094A1 (en) * 2003-10-01 2006-06-28 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DE102004026671A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102004026679A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026670A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
RS50597B (sr) * 2005-02-15 2010-05-07 Jenapharm Gmbh. & Co.Kg. Peroralna dozna forma u čvrstom stanju namenjena kontracepciji koja sadrži dienogest i etinilestradiol
US20060183725A1 (en) * 2005-02-15 2006-08-17 Thomas Graeser Pharmaceutical preparation for oral contraception
EP1690529A1 (de) * 2005-02-15 2006-08-16 Schering AG Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält
US20060205701A1 (en) * 2005-02-15 2006-09-14 Sabine Fricke Solid peroral contraceptive preparations
US20070072836A1 (en) * 2005-02-15 2007-03-29 Sabine Fricke Solid peroral contraceptive preparations
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
MX2008011074A (es) * 2006-03-02 2008-09-10 Warner Chilcott Co Inc Metodo anticonceptivo oral multifasico de ciclo prolongado.
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
CA2740002C (en) * 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
EP2343964A4 (en) 2008-10-08 2012-11-07 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
CA2740005C (en) * 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
WO2010111488A1 (en) * 2009-03-27 2010-09-30 Agile Therapeutics, Inc. Transdermal delivery
HUE065350T2 (hu) * 2015-06-23 2024-05-28 Laboratorios Leon Farma Sa Drospirenonalapú fogamzásgátló túlsúllyal érintett nõi beteg számára
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368373A1 (en) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Multi-phase contraceptive preparation
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5320850A (en) 1990-10-29 1994-06-14 Alza Corporation Transdermal delivery of the gestogen ST-1435 and devices therefor
DE4224534A1 (de) * 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344405C2 (de) 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption

Also Published As

Publication number Publication date
NO976067D0 (no) 1997-12-23
IL122109A (en) 2006-07-05
NO976067L (no) 1998-02-27
DE59610425D1 (de) 2003-06-12
CA2225724C (en) 2008-01-15
ES2199293T3 (es) 2004-02-16
ZA965547B (en) 1997-01-27
JPH11508538A (ja) 1999-07-27
EP0835114A1 (de) 1998-04-15
CN1189101A (zh) 1998-07-29
HUP9900252A3 (en) 2001-09-28
DE19525017A1 (de) 1997-01-02
CA2225724A1 (en) 1997-01-16
BR9609317A (pt) 1999-07-06
HU223976B1 (hu) 2005-03-29
CZ420597A3 (cs) 1998-03-18
NZ312081A (en) 1999-04-29
MX9800026A (es) 1998-03-31
US6027749A (en) 2000-02-22
WO1997001342A1 (de) 1997-01-16
US6312722B1 (en) 2001-11-06
PT835114E (pt) 2003-09-30
SK178097A3 (en) 1998-05-06
HUP9900252A2 (hu) 1999-05-28
IL122109A0 (en) 1998-04-05
EP0835114B1 (de) 2003-05-07
ATE239483T1 (de) 2003-05-15
NO317671B1 (no) 2004-11-29
RU98101254A (ru) 2000-01-27
CN1137690C (zh) 2004-02-11
AU6352896A (en) 1997-01-30

Similar Documents

Publication Publication Date Title
DK0835114T3 (da) Farmaceutisk kombinationspræparat, kit og fremgangsmåde til den hormonale kontraception
US4921843A (en) Contraception system and method
AU1191092A (en) Ovulation-preventing agent for hormonal contraception
HU9602657D0 (en) Combined hormonal contraception pharmaceutical preparation
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
DK351887A (da) Kombinationsdosisform til hormonbehandling og kontraception for kvinder i praemenopausen
TR199802705T2 (xx) Progestojen-anti-progestojen k�r�
PL327182A1 (en) Method of preventing conception among female mammals through combined application of gestagen and oestrogen and combination of active agent therefor
NZ333750A (en) Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
NO974630D0 (no) Farmasöytisk kombinasjonspreparat for hormonell antikonsepsjon
WO1994002103A3 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
DK0921804T3 (da) Tofase oral præventionsmetode og kit som indeholder en kombination af progestin og østrogen
USRE35724E (en) Contraception system and method